Refine by
Biomarker Testing Suppliers & Manufacturers
43 companies found
based inRockville, MARYLAND (USA)
20/20 GeneSystems (“20/20”) is focused on on reducing cancer deaths worldwide through its years of experience in the development and use of cancer biomarker test development. By leveraging this expertise and combining it with advanced machine ...
based inOklahoma City, OKLAHOMA (USA)
By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...
A BIOMARKER BASED TEST TO MEASURE CURRENT DISEASE ACTIVITY. THE AISLE DX DISEASE ACTIVITY TEST SUPPORTS CLINICIANS IN THE MEASUREMENT OF LUPUS (SLE) AND THE ASSESSMENT OF TREATMENTS. BLOOD ...
based inNorthwood, OHIO (USA)
NAMSA is medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. At every stage of the product development process, we provide strategic ...
We use our human skin model to test lead formulations and screen them against a variety of parameters in human skin to ensure clinical success. We perform antimicrobial efficacy testing, biomarker ...
based inBig Lake, MINNESOTA (USA)
Bionote has a long history as a leading research and development company in the animal health diagnostic field. Headquartered in Minnesota, the Bionote USA team works with veterinarians and medical professionals around the world. The leadership ...
Bionote's Vcheck V2400 analyzer for veterinary fluorescence immunoassay can help point-of-care testing for various biomarkers, in-house at larger patient care facilities. It provides quantitative measurement of ...
based inMerion, PENNSYLVANIA (USA)
Glycotest is a liver disease diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis. Founded in 2012 by NetScientific plc on technology originating at the Baruch S. Blumberg ...
Glycotest blood tests are being developed to provide information on the likelihood of serious liver disease like cancer or fibrosis-cirrhosis by employing technology designed to measure two kinds of disease signals: The amount of the monosaccharide ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
Developing Breath Biopsy for clinical applications in early detection and precision ...
based inBeverly, MASSACHUSETTS (USA)
Cellanyx is a growth stage emerging biotech advancing proprietary phenotypic (appearance and dynamics) biomarker tests based on Machine Vision and AI-driven analysis of live single tumor cells to improve risk-stratification and shared clinical ...
based inLoos, FRANCE
GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases. Our translational disease-driven research approach is based on strong expertise, featuring in-house knowledge of ...
Nonalcoholic steatohepatitis (NASH) remains largely underdiagnosed, as it carries no obvious symptoms in its early stages, and also because of the lack of widely available non-invasive tests specifically developed to diagnose the disease. The ...
based inEschborn, GERMANY
When we looked at the decision making landscape in organizations and observed that the available technologies and models were helping make decisions but with fixed cycles of information processing, running in batches, with little flexibility and ...
Identify the biomarkers best suited for your needs: Diagnose rare or ambiguous diseases, Group patients by endotype response for prognosis, Assess disease etiology to determine responsive patient group ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify disease ...
based in
JOANNEUM RESEARCH Forschungsgesellschaft mbH develops solutions and technologies for businesses and industries across a wide range of sectors and conducts top-level research at an international level. With a focus on applied research and technology ...
Biomarkers stand for various characteristics and properties that can be determined in the human body. Biomarkers are becoming increasingly important in medicine - both in diagnostics and in the treatment of diseases. COREMED works with a network of ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging ...
based inRostock, GERMANY
Since 2006, CENTOGENE has helped physicians diagnose thousands of rare disease patients around the world. A quick and accurate diagnosis can end an odyssey of medical tests and visits to multiple medical specialists. It also helps physicians better ...
Genetic testing is a type of medical test that identifies changes in genes, inherited from our parents, which we then typically pass on to our children. “Mistakes” in our genes (called “pathogenic variants”) can manifest the ...
based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid ...
After marker identification, biomarkers and/or gene signatures enter our development process to become targeted assays. The newly identified biomarkers are developed into a Laboratory Developed ...
based inHayward, CALIFORNIA (USA)
Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays through innovation. Our signature technology platform is a proprietary polymer-based detection system. Based on this technology we have developed a series of highly ...
Cluster of Differentiation 20 (CD20) is a polymerized horseradish peroxidase (pHRP)-labeled anti-CD20 (R272) rabbit monoclonal antibody intended for laboratory use using frozen or formalin-fixed-paraffin-embedded tissues. CD20 also known as ...
based inVienna, AUSTRIA
Biomedica is part of the AddLife Group, a publicly traded parent company consisting of various subsidiaries in the Life Science and Medical Device fields. AddLife strives to improve people’s lives by being a leading, value creating player in Life ...
We offer custom testing service measurements for the quantification of biomarkers in biological samples. Our experienced laboratory staff perform all sample service measurements, allowing customers to fully rely on ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
based inGosselies, BELGIUM
We are a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. OncoDNA is a company specializing in precision for the treatment of cancer and other genetic diseases. We are ...
Order OncoDNA's solutions, browse your patients' history and receive your personalised report on treatment recommendations. When you join OncoSHARE, you become a member of an active network gathering together more than 13,000 patients and ...
based inBelfast, UNITED KINGDOM
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by ...
What is DXRX Physician Mapping? DXRX Physician Mapping examines physician testing behavior (US only) using patient level data to determine testing rates, methodology and the physician to lab relationship. DXRX ...
based inFremont, CALIFORNIA (USA)
BioGenex designs, develops and commercializes molecular pathology systems for Tumor diagnosis, prognosis, precision medicine and life science research. BioGenex’s industry-leading next-generation cytogenetic FISH workflow solution and miRNA system ...